ARTICLE | Company News
Cephalon, Champions Biotechnology deal
April 4, 2011 7:00 AM UTC
Champions will use its Biomerk Tumorgraft technology to evaluate the efficacy of Cephalon's CEP-37440 for cancer. The Tumorgraft technology uses implantation of human tumors in immune deficient mice ...